Penumbra annual ebitda margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Penumbra EBITDA Margin Growth & History (PEN)
Penumbra's ebitda margin was 14.73% for fiscal 2025.
View full Penumbra company overviewPenumbra annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 14.73% | +11.97 pp |
| 2024 | 2024-12-31 | 2.76% | −6.76 pp |
| 2023 | 2023-12-31 | 9.52% | +5.93 pp |
| 2022 | 2022-12-31 | 3.59% | +2.40 pp |
| 2021 | 2021-12-31 | 1.19% | +5.84 pp |
| 2020 | 2020-12-31 | −4.65% | −14.81 pp |
| 2019 | 2019-12-31 | 10.16% | +8.96 pp |
| 2018 | 2018-12-31 | 1.19% | −0.29 pp |
| 2017 | 2017-12-31 | 1.48% | +1.12 pp |
| 2016 | 2016-12-31 | 0.36% | −2.83 pp |
| 2015 | 2015-12-31 | 3.19% | +0.19 pp |
| 2014 | 2014-12-31 | 3.00% | +3.50 pp |
| 2013 | 2013-12-31 | −0.51% | — |
Penumbra quarterly ebitda margin
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 11.96% | −1.69 pp |
| Q1 2026 | 2026-03-31 | 11.42% | −2.57 pp |
| Q4 2025 | 2025-12-31 | 16.53% | +1.58 pp |
| Q3 2025 | 2025-09-30 | 14.47% | +1.35 pp |
| Q2 2025 | 2025-06-30 | 13.65% | +38.14 pp |
| Q1 2025 | 2025-03-31 | 14.00% | +6.95 pp |
| Q4 2024 | 2024-12-31 | 14.95% | +0.17 pp |
| Q3 2024 | 2024-09-30 | 13.13% | +5.91 pp |
| Q2 2024 | 2024-06-30 | −24.49% | −33.89 pp |
| Q1 2024 | 2024-03-31 | 7.04% | +1.00 pp |
| Q4 2023 | 2023-12-31 | 14.78% | +9.68 pp |
| Q3 2023 | 2023-09-30 | 7.22% | +1.76 pp |
| Q2 2023 | 2023-06-30 | 9.41% | +6.63 pp |
| Q1 2023 | 2023-03-31 | 6.04% | +5.22 pp |
| Q4 2022 | 2022-12-31 | 5.10% | +21.91 pp |
| Q3 2022 | 2022-09-30 | 5.46% | −1.07 pp |
| Q2 2022 | 2022-06-30 | 2.78% | −4.74 pp |
| Q1 2022 | 2022-03-31 | 0.82% | −9.18 pp |
| Q4 2021 | 2021-12-31 | −16.81% | −17.84 pp |
| Q3 2021 | 2021-09-30 | 6.53% | +17.66 pp |
| Q2 2021 | 2021-06-30 | 7.52% | +21.34 pp |
| Q1 2021 | 2021-03-31 | 10.01% | +7.41 pp |
| Q4 2020 | 2020-12-31 | 1.03% | −7.85 pp |
| Q3 2020 | 2020-09-30 | −11.13% | −21.90 pp |
| Q2 2020 | 2020-06-30 | −13.81% | −24.79 pp |
| Q1 2020 | 2020-03-31 | 2.60% | −7.49 pp |
| Q4 2019 | 2019-12-31 | 8.88% | +1.94 pp |
| Q3 2019 | 2019-09-30 | 10.77% | +28.07 pp |
| Q2 2019 | 2019-06-30 | 10.98% | +1.10 pp |
| Q1 2019 | 2019-03-31 | 10.09% | +4.79 pp |
| Q4 2018 | 2018-12-31 | 6.94% | +1.67 pp |
| Q3 2018 | 2018-09-30 | −17.30% | −19.49 pp |
| Q2 2018 | 2018-06-30 | 9.88% | +10.57 pp |
| Q1 2018 | 2018-03-31 | 5.30% | +7.20 pp |
| Q4 2017 | 2017-12-31 | 5.26% | +6.21 pp |
| Q3 2017 | 2017-09-30 | 2.19% | +3.18 pp |
| Q2 2017 | 2017-06-30 | −0.69% | −0.59 pp |
| Q1 2017 | 2017-03-31 | −1.90% | −6.00 pp |
| Q4 2016 | 2016-12-31 | −0.95% | −5.24 pp |
| Q3 2016 | 2016-09-30 | −0.99% | −6.31 pp |
| Q2 2016 | 2016-06-30 | −0.11% | +7.96 pp |
| Q1 2016 | 2016-03-31 | 4.10% | −7.01 pp |
| Q4 2015 | 2015-12-31 | 4.29% | — |
| Q3 2015 | 2015-09-30 | 5.32% | +3.75 pp |
| Q2 2015 | 2015-06-30 | −8.07% | — |
| Q1 2015 | 2015-03-31 | 11.11% | — |
| Q3 2014 | 2014-09-30 | 1.57% | — |
Penumbra ebitda margin trends
Over the last five fiscal years, Penumbra's ebitda margin increased from −4.65% to 14.73%, a change of +19.38 percentage points. The latest reported quarter, Q2 2026, shows 11.96%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Penumbra source filings ↗Community posts
Penumbra’s thrombectomy business leads 16% quarterly sales growth
Penumbra ($PEN) reported third-quarter 2026 revenue of $410.1 million, up 15.6%, as demand for its clot-removal systems expanded. Thrombectomy sales increased 18.1% to $279.2 million, including 26% growth in the US venous-thromboembolism bu ...
